nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—Vemurafenib—skin cancer	0.186	0.228	CbGbCtD
Atazanavir—ABCC1—Dactinomycin—skin cancer	0.124	0.152	CbGbCtD
Atazanavir—SLCO1B3—Docetaxel—skin cancer	0.0923	0.113	CbGbCtD
Atazanavir—ABCC1—Docetaxel—skin cancer	0.0638	0.0783	CbGbCtD
Atazanavir—CYP2C9—Vismodegib—skin cancer	0.0585	0.0717	CbGbCtD
Atazanavir—ABCB1—Vismodegib—skin cancer	0.0568	0.0696	CbGbCtD
Atazanavir—CYP3A4—Imiquimod—skin cancer	0.0491	0.0602	CbGbCtD
Atazanavir—CYP3A4—Temozolomide—skin cancer	0.0491	0.0602	CbGbCtD
Atazanavir—CYP3A4—Vismodegib—skin cancer	0.034	0.0417	CbGbCtD
Atazanavir—ABCB1—Dactinomycin—skin cancer	0.0298	0.0366	CbGbCtD
Atazanavir—CYP3A4—Vemurafenib—skin cancer	0.0269	0.033	CbGbCtD
Atazanavir—CYP2C9—Fluorouracil—skin cancer	0.0208	0.0255	CbGbCtD
Atazanavir—ABCB1—Docetaxel—skin cancer	0.0154	0.0189	CbGbCtD
Atazanavir—CYP3A4—Docetaxel—skin cancer	0.00923	0.0113	CbGbCtD
Atazanavir—Decreased appetite—Imiquimod—skin cancer	0.000328	0.00178	CcSEcCtD
Atazanavir—Hypersensitivity—Vemurafenib—skin cancer	0.000326	0.00177	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Imiquimod—skin cancer	0.000326	0.00177	CcSEcCtD
Atazanavir—Fatigue—Imiquimod—skin cancer	0.000326	0.00177	CcSEcCtD
Atazanavir—Pain—Imiquimod—skin cancer	0.000323	0.00175	CcSEcCtD
Atazanavir—Neuropathy peripheral—Fluorouracil—skin cancer	0.000321	0.00174	CcSEcCtD
Atazanavir—Dermatitis bullous—Docetaxel—skin cancer	0.000321	0.00174	CcSEcCtD
Atazanavir—Stomatitis—Fluorouracil—skin cancer	0.000319	0.00173	CcSEcCtD
Atazanavir—Hepatitis—Temozolomide—skin cancer	0.000319	0.00173	CcSEcCtD
Atazanavir—Urinary tract infection—Fluorouracil—skin cancer	0.000318	0.00172	CcSEcCtD
Atazanavir—Asthenia—Vemurafenib—skin cancer	0.000318	0.00172	CcSEcCtD
Atazanavir—Hypoaesthesia—Temozolomide—skin cancer	0.000317	0.00172	CcSEcCtD
Atazanavir—Hallucination—Temozolomide—skin cancer	0.000317	0.00172	CcSEcCtD
Atazanavir—Urinary tract disorder—Temozolomide—skin cancer	0.000315	0.00171	CcSEcCtD
Atazanavir—Oedema peripheral—Temozolomide—skin cancer	0.000314	0.0017	CcSEcCtD
Atazanavir—Pruritus—Vemurafenib—skin cancer	0.000313	0.0017	CcSEcCtD
Atazanavir—Connective tissue disorder—Temozolomide—skin cancer	0.000313	0.0017	CcSEcCtD
Atazanavir—Urethral disorder—Temozolomide—skin cancer	0.000312	0.00169	CcSEcCtD
Atazanavir—Alopecia—Dactinomycin—skin cancer	0.000311	0.00169	CcSEcCtD
Atazanavir—Feeling abnormal—Imiquimod—skin cancer	0.000311	0.00169	CcSEcCtD
Atazanavir—Gastrointestinal pain—Imiquimod—skin cancer	0.000309	0.00167	CcSEcCtD
Atazanavir—Pain in extremity—Docetaxel—skin cancer	0.000306	0.00166	CcSEcCtD
Atazanavir—Ill-defined disorder—Bleomycin—skin cancer	0.000305	0.00165	CcSEcCtD
Atazanavir—Diarrhoea—Vemurafenib—skin cancer	0.000303	0.00164	CcSEcCtD
Atazanavir—Erythema multiforme—Temozolomide—skin cancer	0.000301	0.00163	CcSEcCtD
Atazanavir—Urticaria—Imiquimod—skin cancer	0.0003	0.00163	CcSEcCtD
Atazanavir—Abdominal pain—Imiquimod—skin cancer	0.000299	0.00162	CcSEcCtD
Atazanavir—Body temperature increased—Imiquimod—skin cancer	0.000299	0.00162	CcSEcCtD
Atazanavir—Eye disorder—Temozolomide—skin cancer	0.000298	0.00161	CcSEcCtD
Atazanavir—Tinnitus—Temozolomide—skin cancer	0.000297	0.00161	CcSEcCtD
Atazanavir—Malaise—Bleomycin—skin cancer	0.000297	0.00161	CcSEcCtD
Atazanavir—Cardiac disorder—Temozolomide—skin cancer	0.000296	0.0016	CcSEcCtD
Atazanavir—Dizziness—Vemurafenib—skin cancer	0.000293	0.00159	CcSEcCtD
Atazanavir—Hypoaesthesia—Fluorouracil—skin cancer	0.000292	0.00158	CcSEcCtD
Atazanavir—Angiopathy—Temozolomide—skin cancer	0.000289	0.00157	CcSEcCtD
Atazanavir—Immune system disorder—Temozolomide—skin cancer	0.000288	0.00156	CcSEcCtD
Atazanavir—Mediastinal disorder—Temozolomide—skin cancer	0.000287	0.00156	CcSEcCtD
Atazanavir—Cough—Bleomycin—skin cancer	0.000287	0.00156	CcSEcCtD
Atazanavir—Dehydration—Docetaxel—skin cancer	0.000285	0.00154	CcSEcCtD
Atazanavir—Ill-defined disorder—Dactinomycin—skin cancer	0.000285	0.00154	CcSEcCtD
Atazanavir—Vomiting—Vemurafenib—skin cancer	0.000282	0.00153	CcSEcCtD
Atazanavir—Alopecia—Temozolomide—skin cancer	0.000282	0.00153	CcSEcCtD
Atazanavir—Dry skin—Docetaxel—skin cancer	0.000281	0.00152	CcSEcCtD
Atazanavir—Chest pain—Bleomycin—skin cancer	0.00028	0.00152	CcSEcCtD
Atazanavir—Myalgia—Bleomycin—skin cancer	0.00028	0.00152	CcSEcCtD
Atazanavir—Rash—Vemurafenib—skin cancer	0.000279	0.00151	CcSEcCtD
Atazanavir—Mental disorder—Temozolomide—skin cancer	0.000279	0.00151	CcSEcCtD
Atazanavir—Dermatitis—Vemurafenib—skin cancer	0.000279	0.00151	CcSEcCtD
Atazanavir—Hypersensitivity—Imiquimod—skin cancer	0.000278	0.00151	CcSEcCtD
Atazanavir—Headache—Vemurafenib—skin cancer	0.000278	0.0015	CcSEcCtD
Atazanavir—Malnutrition—Temozolomide—skin cancer	0.000277	0.0015	CcSEcCtD
Atazanavir—Breast disorder—Docetaxel—skin cancer	0.000277	0.0015	CcSEcCtD
Atazanavir—Discomfort—Bleomycin—skin cancer	0.000277	0.0015	CcSEcCtD
Atazanavir—Malaise—Dactinomycin—skin cancer	0.000277	0.0015	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000276	0.0015	CcSEcCtD
Atazanavir—Nasopharyngitis—Docetaxel—skin cancer	0.000274	0.00148	CcSEcCtD
Atazanavir—Dysgeusia—Temozolomide—skin cancer	0.000272	0.00147	CcSEcCtD
Atazanavir—Asthenia—Imiquimod—skin cancer	0.000271	0.00147	CcSEcCtD
Atazanavir—Confusional state—Bleomycin—skin cancer	0.000271	0.00147	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00027	0.00146	CcSEcCtD
Atazanavir—Oedema—Bleomycin—skin cancer	0.000268	0.00145	CcSEcCtD
Atazanavir—Back pain—Temozolomide—skin cancer	0.000268	0.00145	CcSEcCtD
Atazanavir—Pruritus—Imiquimod—skin cancer	0.000267	0.00145	CcSEcCtD
Atazanavir—Infection—Bleomycin—skin cancer	0.000267	0.00145	CcSEcCtD
Atazanavir—Nausea—Vemurafenib—skin cancer	0.000263	0.00143	CcSEcCtD
Atazanavir—Myalgia—Dactinomycin—skin cancer	0.000261	0.00142	CcSEcCtD
Atazanavir—Alopecia—Fluorouracil—skin cancer	0.000259	0.00141	CcSEcCtD
Atazanavir—Diarrhoea—Imiquimod—skin cancer	0.000258	0.0014	CcSEcCtD
Atazanavir—Discomfort—Dactinomycin—skin cancer	0.000258	0.0014	CcSEcCtD
Atazanavir—Ill-defined disorder—Temozolomide—skin cancer	0.000257	0.0014	CcSEcCtD
Atazanavir—Anorexia—Bleomycin—skin cancer	0.000256	0.00139	CcSEcCtD
Atazanavir—Agitation—Temozolomide—skin cancer	0.000255	0.00138	CcSEcCtD
Atazanavir—Angioedema—Temozolomide—skin cancer	0.000253	0.00137	CcSEcCtD
Atazanavir—Oedema—Dactinomycin—skin cancer	0.00025	0.00136	CcSEcCtD
Atazanavir—Malaise—Temozolomide—skin cancer	0.00025	0.00136	CcSEcCtD
Atazanavir—Dizziness—Imiquimod—skin cancer	0.00025	0.00135	CcSEcCtD
Atazanavir—Infection—Dactinomycin—skin cancer	0.000249	0.00135	CcSEcCtD
Atazanavir—Neutropenia—Docetaxel—skin cancer	0.000248	0.00134	CcSEcCtD
Atazanavir—Palpitations—Temozolomide—skin cancer	0.000245	0.00133	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000245	0.00133	CcSEcCtD
Atazanavir—Cough—Temozolomide—skin cancer	0.000242	0.00131	CcSEcCtD
Atazanavir—Weight increased—Docetaxel—skin cancer	0.000241	0.00131	CcSEcCtD
Atazanavir—Convulsion—Temozolomide—skin cancer	0.00024	0.0013	CcSEcCtD
Atazanavir—Vomiting—Imiquimod—skin cancer	0.00024	0.0013	CcSEcCtD
Atazanavir—Weight decreased—Docetaxel—skin cancer	0.00024	0.0013	CcSEcCtD
Atazanavir—Hypertension—Temozolomide—skin cancer	0.00024	0.0013	CcSEcCtD
Atazanavir—Dyspnoea—Bleomycin—skin cancer	0.000239	0.0013	CcSEcCtD
Atazanavir—Anorexia—Dactinomycin—skin cancer	0.000239	0.00129	CcSEcCtD
Atazanavir—Rash—Imiquimod—skin cancer	0.000238	0.00129	CcSEcCtD
Atazanavir—Dermatitis—Imiquimod—skin cancer	0.000238	0.00129	CcSEcCtD
Atazanavir—Headache—Imiquimod—skin cancer	0.000237	0.00128	CcSEcCtD
Atazanavir—Arthralgia—Temozolomide—skin cancer	0.000236	0.00128	CcSEcCtD
Atazanavir—Myalgia—Temozolomide—skin cancer	0.000236	0.00128	CcSEcCtD
Atazanavir—Anxiety—Temozolomide—skin cancer	0.000235	0.00128	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000235	0.00127	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000234	0.00127	CcSEcCtD
Atazanavir—Discomfort—Temozolomide—skin cancer	0.000233	0.00126	CcSEcCtD
Atazanavir—Decreased appetite—Bleomycin—skin cancer	0.000233	0.00126	CcSEcCtD
Atazanavir—Renal failure—Docetaxel—skin cancer	0.000232	0.00126	CcSEcCtD
Atazanavir—Neuropathy peripheral—Docetaxel—skin cancer	0.000231	0.00125	CcSEcCtD
Atazanavir—Dry mouth—Temozolomide—skin cancer	0.000231	0.00125	CcSEcCtD
Atazanavir—Jaundice—Docetaxel—skin cancer	0.00023	0.00125	CcSEcCtD
Atazanavir—Stomatitis—Docetaxel—skin cancer	0.00023	0.00125	CcSEcCtD
Atazanavir—Pain—Bleomycin—skin cancer	0.00023	0.00124	CcSEcCtD
Atazanavir—Confusional state—Temozolomide—skin cancer	0.000228	0.00124	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000228	0.00124	CcSEcCtD
Atazanavir—Oedema—Temozolomide—skin cancer	0.000226	0.00123	CcSEcCtD
Atazanavir—Infection—Temozolomide—skin cancer	0.000225	0.00122	CcSEcCtD
Atazanavir—Nausea—Imiquimod—skin cancer	0.000224	0.00122	CcSEcCtD
Atazanavir—Hepatobiliary disease—Docetaxel—skin cancer	0.000223	0.00121	CcSEcCtD
Atazanavir—Nervous system disorder—Temozolomide—skin cancer	0.000222	0.0012	CcSEcCtD
Atazanavir—Convulsion—Fluorouracil—skin cancer	0.000221	0.0012	CcSEcCtD
Atazanavir—Feeling abnormal—Bleomycin—skin cancer	0.000221	0.0012	CcSEcCtD
Atazanavir—Skin disorder—Temozolomide—skin cancer	0.00022	0.00119	CcSEcCtD
Atazanavir—Hyperhidrosis—Temozolomide—skin cancer	0.000219	0.00119	CcSEcCtD
Atazanavir—Chest pain—Fluorouracil—skin cancer	0.000218	0.00118	CcSEcCtD
Atazanavir—Myalgia—Fluorouracil—skin cancer	0.000218	0.00118	CcSEcCtD
Atazanavir—Decreased appetite—Dactinomycin—skin cancer	0.000218	0.00118	CcSEcCtD
Atazanavir—Fatigue—Dactinomycin—skin cancer	0.000216	0.00117	CcSEcCtD
Atazanavir—Anorexia—Temozolomide—skin cancer	0.000216	0.00117	CcSEcCtD
Atazanavir—Discomfort—Fluorouracil—skin cancer	0.000215	0.00117	CcSEcCtD
Atazanavir—Pain—Dactinomycin—skin cancer	0.000214	0.00116	CcSEcCtD
Atazanavir—Urticaria—Bleomycin—skin cancer	0.000213	0.00116	CcSEcCtD
Atazanavir—Body temperature increased—Bleomycin—skin cancer	0.000212	0.00115	CcSEcCtD
Atazanavir—Hepatitis—Docetaxel—skin cancer	0.000212	0.00115	CcSEcCtD
Atazanavir—Hypoaesthesia—Docetaxel—skin cancer	0.000211	0.00114	CcSEcCtD
Atazanavir—Confusional state—Fluorouracil—skin cancer	0.00021	0.00114	CcSEcCtD
Atazanavir—Urinary tract disorder—Docetaxel—skin cancer	0.000209	0.00113	CcSEcCtD
Atazanavir—Oedema peripheral—Docetaxel—skin cancer	0.000209	0.00113	CcSEcCtD
Atazanavir—Oedema—Fluorouracil—skin cancer	0.000209	0.00113	CcSEcCtD
Atazanavir—Connective tissue disorder—Docetaxel—skin cancer	0.000208	0.00113	CcSEcCtD
Atazanavir—Urethral disorder—Docetaxel—skin cancer	0.000208	0.00113	CcSEcCtD
Atazanavir—Infection—Fluorouracil—skin cancer	0.000207	0.00112	CcSEcCtD
Atazanavir—Feeling abnormal—Dactinomycin—skin cancer	0.000206	0.00112	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000206	0.00112	CcSEcCtD
Atazanavir—Insomnia—Temozolomide—skin cancer	0.000205	0.00111	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dactinomycin—skin cancer	0.000205	0.00111	CcSEcCtD
Atazanavir—Nervous system disorder—Fluorouracil—skin cancer	0.000205	0.00111	CcSEcCtD
Atazanavir—Dyspnoea—Temozolomide—skin cancer	0.000202	0.00109	CcSEcCtD
Atazanavir—Somnolence—Temozolomide—skin cancer	0.000201	0.00109	CcSEcCtD
Atazanavir—Erythema multiforme—Docetaxel—skin cancer	0.0002	0.00109	CcSEcCtD
Atazanavir—Dyspepsia—Temozolomide—skin cancer	0.000199	0.00108	CcSEcCtD
Atazanavir—Anorexia—Fluorouracil—skin cancer	0.000199	0.00108	CcSEcCtD
Atazanavir—Eye disorder—Docetaxel—skin cancer	0.000198	0.00107	CcSEcCtD
Atazanavir—Abdominal pain—Dactinomycin—skin cancer	0.000198	0.00107	CcSEcCtD
Atazanavir—Body temperature increased—Dactinomycin—skin cancer	0.000198	0.00107	CcSEcCtD
Atazanavir—Hypersensitivity—Bleomycin—skin cancer	0.000198	0.00107	CcSEcCtD
Atazanavir—Decreased appetite—Temozolomide—skin cancer	0.000197	0.00107	CcSEcCtD
Atazanavir—Cardiac disorder—Docetaxel—skin cancer	0.000197	0.00107	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Temozolomide—skin cancer	0.000195	0.00106	CcSEcCtD
Atazanavir—Fatigue—Temozolomide—skin cancer	0.000195	0.00106	CcSEcCtD
Atazanavir—Constipation—Temozolomide—skin cancer	0.000194	0.00105	CcSEcCtD
Atazanavir—Pain—Temozolomide—skin cancer	0.000194	0.00105	CcSEcCtD
Atazanavir—Asthenia—Bleomycin—skin cancer	0.000193	0.00104	CcSEcCtD
Atazanavir—Angiopathy—Docetaxel—skin cancer	0.000192	0.00104	CcSEcCtD
Atazanavir—Immune system disorder—Docetaxel—skin cancer	0.000191	0.00104	CcSEcCtD
Atazanavir—Mediastinal disorder—Docetaxel—skin cancer	0.000191	0.00104	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00019	0.00103	CcSEcCtD
Atazanavir—Pruritus—Bleomycin—skin cancer	0.00019	0.00103	CcSEcCtD
Atazanavir—Insomnia—Fluorouracil—skin cancer	0.000189	0.00102	CcSEcCtD
Atazanavir—Alopecia—Docetaxel—skin cancer	0.000187	0.00102	CcSEcCtD
Atazanavir—Feeling abnormal—Temozolomide—skin cancer	0.000187	0.00101	CcSEcCtD
Atazanavir—Dyspnoea—Fluorouracil—skin cancer	0.000186	0.00101	CcSEcCtD
Atazanavir—Mental disorder—Docetaxel—skin cancer	0.000186	0.00101	CcSEcCtD
Atazanavir—Somnolence—Fluorouracil—skin cancer	0.000185	0.00101	CcSEcCtD
Atazanavir—Gastrointestinal pain—Temozolomide—skin cancer	0.000185	0.001	CcSEcCtD
Atazanavir—Malnutrition—Docetaxel—skin cancer	0.000184	0.001	CcSEcCtD
Atazanavir—Hypersensitivity—Dactinomycin—skin cancer	0.000184	0.001	CcSEcCtD
Atazanavir—Dyspepsia—Fluorouracil—skin cancer	0.000184	0.000995	CcSEcCtD
Atazanavir—Decreased appetite—Fluorouracil—skin cancer	0.000181	0.000983	CcSEcCtD
Atazanavir—Dysgeusia—Docetaxel—skin cancer	0.000181	0.000979	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00018	0.000976	CcSEcCtD
Atazanavir—Urticaria—Temozolomide—skin cancer	0.00018	0.000975	CcSEcCtD
Atazanavir—Asthenia—Dactinomycin—skin cancer	0.00018	0.000974	CcSEcCtD
Atazanavir—Abdominal pain—Temozolomide—skin cancer	0.000179	0.00097	CcSEcCtD
Atazanavir—Body temperature increased—Temozolomide—skin cancer	0.000179	0.00097	CcSEcCtD
Atazanavir—Back pain—Docetaxel—skin cancer	0.000178	0.000967	CcSEcCtD
Atazanavir—Pain—Fluorouracil—skin cancer	0.000178	0.000967	CcSEcCtD
Atazanavir—Feeling abnormal—Fluorouracil—skin cancer	0.000172	0.000932	CcSEcCtD
Atazanavir—Diarrhoea—Dactinomycin—skin cancer	0.000171	0.000928	CcSEcCtD
Atazanavir—Vomiting—Bleomycin—skin cancer	0.000171	0.000925	CcSEcCtD
Atazanavir—Rash—Bleomycin—skin cancer	0.000169	0.000917	CcSEcCtD
Atazanavir—Dermatitis—Bleomycin—skin cancer	0.000169	0.000916	CcSEcCtD
Atazanavir—Hypersensitivity—Temozolomide—skin cancer	0.000167	0.000904	CcSEcCtD
Atazanavir—Urticaria—Fluorouracil—skin cancer	0.000166	0.000898	CcSEcCtD
Atazanavir—Syncope—Docetaxel—skin cancer	0.000165	0.000897	CcSEcCtD
Atazanavir—Body temperature increased—Fluorouracil—skin cancer	0.000165	0.000894	CcSEcCtD
Atazanavir—Palpitations—Docetaxel—skin cancer	0.000163	0.000884	CcSEcCtD
Atazanavir—Asthenia—Temozolomide—skin cancer	0.000162	0.000881	CcSEcCtD
Atazanavir—Loss of consciousness—Docetaxel—skin cancer	0.000162	0.000879	CcSEcCtD
Atazanavir—Cough—Docetaxel—skin cancer	0.000161	0.000873	CcSEcCtD
Atazanavir—Pruritus—Temozolomide—skin cancer	0.00016	0.000868	CcSEcCtD
Atazanavir—Convulsion—Docetaxel—skin cancer	0.00016	0.000866	CcSEcCtD
Atazanavir—Nausea—Bleomycin—skin cancer	0.000159	0.000864	CcSEcCtD
Atazanavir—Hypertension—Docetaxel—skin cancer	0.000159	0.000863	CcSEcCtD
Atazanavir—Vomiting—Dactinomycin—skin cancer	0.000159	0.000863	CcSEcCtD
Atazanavir—Rash—Dactinomycin—skin cancer	0.000158	0.000856	CcSEcCtD
Atazanavir—Chest pain—Docetaxel—skin cancer	0.000157	0.000851	CcSEcCtD
Atazanavir—Myalgia—Docetaxel—skin cancer	0.000157	0.000851	CcSEcCtD
Atazanavir—Arthralgia—Docetaxel—skin cancer	0.000157	0.000851	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000156	0.000845	CcSEcCtD
Atazanavir—Diarrhoea—Temozolomide—skin cancer	0.000155	0.00084	CcSEcCtD
Atazanavir—Hypersensitivity—Fluorouracil—skin cancer	0.000154	0.000833	CcSEcCtD
Atazanavir—Dry mouth—Docetaxel—skin cancer	0.000154	0.000833	CcSEcCtD
Atazanavir—Confusional state—Docetaxel—skin cancer	0.000152	0.000823	CcSEcCtD
Atazanavir—Oedema—Docetaxel—skin cancer	0.000151	0.000816	CcSEcCtD
Atazanavir—Dizziness—Temozolomide—skin cancer	0.00015	0.000812	CcSEcCtD
Atazanavir—Infection—Docetaxel—skin cancer	0.00015	0.000811	CcSEcCtD
Atazanavir—Nausea—Dactinomycin—skin cancer	0.000149	0.000806	CcSEcCtD
Atazanavir—Shock—Docetaxel—skin cancer	0.000148	0.000803	CcSEcCtD
Atazanavir—Nervous system disorder—Docetaxel—skin cancer	0.000148	0.0008	CcSEcCtD
Atazanavir—Pruritus—Fluorouracil—skin cancer	0.000148	0.0008	CcSEcCtD
Atazanavir—Skin disorder—Docetaxel—skin cancer	0.000146	0.000793	CcSEcCtD
Atazanavir—Vomiting—Temozolomide—skin cancer	0.000144	0.00078	CcSEcCtD
Atazanavir—Anorexia—Docetaxel—skin cancer	0.000144	0.000778	CcSEcCtD
Atazanavir—Rash—Temozolomide—skin cancer	0.000143	0.000774	CcSEcCtD
Atazanavir—Diarrhoea—Fluorouracil—skin cancer	0.000143	0.000774	CcSEcCtD
Atazanavir—Dermatitis—Temozolomide—skin cancer	0.000143	0.000773	CcSEcCtD
Atazanavir—Headache—Temozolomide—skin cancer	0.000142	0.000769	CcSEcCtD
Atazanavir—Dizziness—Fluorouracil—skin cancer	0.000138	0.000748	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000137	0.000744	CcSEcCtD
Atazanavir—Insomnia—Docetaxel—skin cancer	0.000136	0.000738	CcSEcCtD
Atazanavir—Nausea—Temozolomide—skin cancer	0.000134	0.000729	CcSEcCtD
Atazanavir—Dyspnoea—Docetaxel—skin cancer	0.000134	0.000728	CcSEcCtD
Atazanavir—Somnolence—Docetaxel—skin cancer	0.000134	0.000726	CcSEcCtD
Atazanavir—Vomiting—Fluorouracil—skin cancer	0.000133	0.000719	CcSEcCtD
Atazanavir—Dyspepsia—Docetaxel—skin cancer	0.000133	0.000718	CcSEcCtD
Atazanavir—Rash—Fluorouracil—skin cancer	0.000132	0.000713	CcSEcCtD
Atazanavir—Dermatitis—Fluorouracil—skin cancer	0.000131	0.000712	CcSEcCtD
Atazanavir—Decreased appetite—Docetaxel—skin cancer	0.000131	0.000709	CcSEcCtD
Atazanavir—Headache—Fluorouracil—skin cancer	0.000131	0.000708	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Docetaxel—skin cancer	0.00013	0.000705	CcSEcCtD
Atazanavir—Fatigue—Docetaxel—skin cancer	0.00013	0.000704	CcSEcCtD
Atazanavir—Pain—Docetaxel—skin cancer	0.000129	0.000698	CcSEcCtD
Atazanavir—Constipation—Docetaxel—skin cancer	0.000129	0.000698	CcSEcCtD
Atazanavir—Feeling abnormal—Docetaxel—skin cancer	0.000124	0.000673	CcSEcCtD
Atazanavir—Nausea—Fluorouracil—skin cancer	0.000124	0.000672	CcSEcCtD
Atazanavir—Gastrointestinal pain—Docetaxel—skin cancer	0.000123	0.000667	CcSEcCtD
Atazanavir—Body temperature increased—Docetaxel—skin cancer	0.000119	0.000645	CcSEcCtD
Atazanavir—Abdominal pain—Docetaxel—skin cancer	0.000119	0.000645	CcSEcCtD
Atazanavir—Hypersensitivity—Docetaxel—skin cancer	0.000111	0.000601	CcSEcCtD
Atazanavir—Asthenia—Docetaxel—skin cancer	0.000108	0.000586	CcSEcCtD
Atazanavir—Pruritus—Docetaxel—skin cancer	0.000107	0.000577	CcSEcCtD
Atazanavir—Diarrhoea—Docetaxel—skin cancer	0.000103	0.000558	CcSEcCtD
Atazanavir—Dizziness—Docetaxel—skin cancer	9.96e-05	0.00054	CcSEcCtD
Atazanavir—Vomiting—Docetaxel—skin cancer	9.57e-05	0.000519	CcSEcCtD
Atazanavir—Rash—Docetaxel—skin cancer	9.49e-05	0.000515	CcSEcCtD
Atazanavir—Dermatitis—Docetaxel—skin cancer	9.48e-05	0.000514	CcSEcCtD
Atazanavir—Headache—Docetaxel—skin cancer	9.43e-05	0.000511	CcSEcCtD
Atazanavir—Nausea—Docetaxel—skin cancer	8.94e-05	0.000485	CcSEcCtD
